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        Introduction 
  Axons represent the key cellular outgrowth that permits con-
nectivity between distant neurons or neurons and their non-
neuronal targets (e.g., muscles). Axons can be extremely long, 
traversing great distances, and in most neurons, the axonal 
compartment composes the majority of the cellular volume. 
Because of the signifi  cant length and volume of the axon, its 
stabilization represents a major and ongoing challenge for 
neuronal cell types. 
  Wallerian degeneration serves as an extremely useful con-
text in which to study molecular and cellular mechanisms that 
mediate axon integrity. Acute axotomy induces large-scale axon 
degeneration after a defi   ned latent phase that bears striking 
  resemblance to axon degeneration during developmental prun-
ing (  Luo and O  ’  Leary, 2005  ) and in neurodegenerative disease 
(  Coleman, 2005  ). Wallerian degeneration was long thought to 
represent a passive wasting away of the distal portion of the 
severed axons (  Waller, 1850  ) caused by a lack of nutrients from 
the cell body, but a revolution in our understanding of axon biol-
ogy came with the discovery of the spontaneous   C57BL/slow 
Wallerian degeneration   ( Wld 
S   )  mutant  mouse. Amazingly,  sev-
ered  Wld 
S    mutant axons survived for weeks after axotomy ( Lunn 
et al., 1989  ;   Glass et al., 1993  ). This observation indicated that 
the   Wld 
S     mutation somehow suppressed axon autodestruction 
and suggested for the fi   rst time that Wallerian degeneration 
might be an active process of axon autodestruction akin to apop-
totic cell death (  Coleman and Perry, 2002  ;   Raff et al., 2002  ). 
Subsequent analysis of the   Wld 
S     mutant has provided intriguing 
insights into the molecular relationships between axon degener-
ation in developmental, injury, and disease contexts. For example, 
the   Wld 
S     mutation can suppress axon degeneration induced by 
chemical toxicity (  Wang et al., 2001  ), nerve crush (  Beirowski 
et al., 2005  ), and mouse models of neurodegenerative disease 
(  Ferri et al., 2003  ;   Coleman, 2005  ), suggesting that the underlying 
  S
low Wallerian degeneration   (  Wld 
S    ) encodes a 
chimeric Ube4b/nicotinamide mononucleotide 
adenylyl transferase 1 (Nmnat1) fusion protein 
that potently suppresses Wallerian degeneration, but the 
mechanistic action of Wld 
S   remains controversial. In this 
study, we characterize Wld 
S  -mediated axon protection 
in vivo using   Drosophila melanogaster  . We show that 
Nmnat1 can protect severed axons from autodestruction 
but at levels signiﬁ  cantly lower than Wld 
S  , and enzyme-
dead versions of Nmnat1 and Wld 
S   exhibit severely re-
duced axon-protective function. Interestingly, a 16 –  amino 
acid N-terminal domain of Wld 
S   (termed N16) accounts 
for the differences in axon-sparing activity between 
Wld 
S   and Nmnat1, and N16-dependent enhancement 
of Nmnat1-protective activity in Wld 
S   requires the N16-
binding protein valosin-containing protein (VCP)/TER94. 
Thus, Wld 
S  -mediated suppression of Wallerian degener-
ation results from VCP  –  N16 interactions and Nmnat1 
activity converging in vivo. Surprisingly, mouse Nmnat3, 
a mitochondrial Nmnat enzyme that localizes to the 
  cytoplasm in   Drosophila   cells, protects severed axons at 
levels indistinguishable from Wld 
S  . Thus, nuclear Nmnat 
activity does not appear to be essential for Wld 
S  -like 
axon protection.
  Wld 
S   requires Nmnat1 enzymatic activity and N16  –
  VCP interactions to suppress Wallerian degeneration 
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  Three main models have been proposed to explain Wld 
S -
mediated axon protection. The fi  rst argues that Ube4b may 
have a dominant-negative effect on the ubiquitin proteasome 
(UPS) pathway. Although the N70 portion of Ube4b does not 
have ubiquitination activity on its own, it contains domains 
capable of binding Ube4b substrates, implying that N70 may 
bind key substrates in vivo, fail to target them for degradation, 
and, in turn, somehow stabilize severed axons. Consistent with 
this model, the UPS pathway has been shown to be essential in 
promoting axon autodestruction during Wallerian degenera-
tion (  Zhai et al., 2003  ) and developmental axon pruning (  Watts 
et al., 2003  ), but a direct functional link between Wld 
S   and  the 
UPS pathway is lacking. A second hypothesis is that Nmnat1, 
a NAD 
+   biosynthetic enzyme, acts to produce excess NAD 
+  
in the axon after injury and thereby stabilize the axon. Two 
groups reported that application of NAD 
+   or its precursors to 
neuronal cultures partially suppressed axon degeneration in 
vitro (  Araki et al., 2004  ;   Wang et al., 2005  ); however, a third 
study found no enhancement of survival of severed axons from 
programs that drive axon autodestruction in these distinct de-
generative contexts share common molecular features. However, 
  Wld 
S     does not suppress axon degeneration during developmental 
axon pruning in   Drosophila melanogaster   or mammals   (  Hoopfer 
et al., 2006  ), arguing that Wld 
S  -independent molecular programs 
drive axon degeneration in developmental settings. 
 The   Wld 
S     mutation was recently found to result in the 
  fusion of two genes, the NAD 
+   biosynthetic molecule   nico-
tinamide mononucleotide adenylyl transferase 1   ( nmnat1 )  and 
  Ube4b  , an E4 ubiquitin ligase (  Conforti et al., 2000  ;   Mack 
et al., 2001  ). The protein encoded by this locus, termed Wld 
S  
(  Fig. 1 A  ), is composed of the N-terminal 70 amino acids of 
Ube4b (termed N70), a unique 18  –  amino acid domain gener-
ated during the gene fusion event (termed W18), and the full-
length sequence of mouse   nmnat1  . Expression of this protein in 
mouse neurons fully recapitulates the   Wld 
S     mutant phenotype 
(  Mack et al., 2001  ) and can even protect severed axons from 
  autodestruction in distant species like   Drosophila   (  Hoopfer et al., 
2006  ;   MacDonald et al., 2006  ). 
  Figure 1.       Constructs used to dissect Wld 
S   functional domains and localization in   Drosophila   neurons.   (A) All constructs were generated from mouse Wld 
S  , 
which contains N70, the ﬁ  rst 16 amino acids (N16) that encode the VCP-binding site, W18, an 18  –  amino acid linker, and full-length Nmnat1. Nmnat1 
dead   
harbors an H24A mutation; Wld 
S    N16   lacks the N16 domain; N16-Nmnat1 is N16 tethered to the N terminus of Nmnat1; Wld 
S-dead   is full-length Wld 
S   
with an H24A mutation in Nmnat1. See Materials and methods for details. (B  –  G)   UAS-Wld 
S  –Myc   (B and C),   UAS-Wld 
S-dead  –Myc   (D and E), and   UAS-
Nmnat1–myc   (F and G) were expressed with   UAS-mCD8–GFP   in projection neurons using   GH146-Gal4  . The arrows point to nuclei, and the arrowheads 
point to axons. Bar, 12.14   μ  m.     503 IN VIVO FUNCTIONAL DISSECTION OF WLD 
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strate conversion to NAD 
+   (  Saridakis et al., 2001  ); (c)   UAS-
Wld 
S-   N16   ,  Wld 
S   with a deletion of the fi  rst 16 amino acids 
(termed N16), which was previously shown to bind VCP (  Laser 
et al., 2006  ); (d)   UAS-N16–nmnat1  , a fusion of N16 to full-
length Nmnat1; and (e)   UAS-Wld 
S-dead   ,  full-length  Wld 
S   with 
an H24A substitution in the Nmnat1 portion of the molecule. 
To determine the subcellular localization of Wld 
S   and  the 
aforementioned variants, we also generated C-terminally Myc 
epitope – tagged  versions  of  Wld 
S ,  Wld 
S-dead  , and Nmnat1 (  UAS-
Wld 
S  – Myc ,   UAS-Wld 
S-dead  – Myc ,  and   UAS-Nmnat1 – Myc ).  When 
expressed in   Drosophila  , antennal lobe projection neurons in 
the central brain of all of these molecules localized exclusively 
to the nucleus (  Fig. 1, B  –  G  ), indicating that the H24A muta-
tions that abolish NAD 
+   biosynthetic activity do not alter the 
subcellular localization of Wld 
S  . We further note the conspicu-
ous absence of Wld 
S+   nuclear puncta in   Drosophila   neurons 
(  Fig. 1, B and C  ) and S2 cells (see   Fig. 5, A and B  ) that have 
been observed when Wld 
S   is expressed in mammalian cell 
lines (  Laser et al., 2006  ). Thus, Wld 
S   localizes to the nucleus in 
  Drosophila   neurons, and these data argue that the presence of 
Wld 
S+   nuclear puncta is not essential for Wld 
S   to exert its neuro-
protective effects. 
  Multiple transgenic lines were established for each con-
struct, and at least three lines bearing independently isolated 
transgene insertions were assayed for protein expression levels 
(  Fig. 2  ) and functional protection (see following section). 
The effi  ciency of protein expression from each transgene was 
assayed by crossing individual UAS lines to the panneuronal 
driver   elav-Gal4  , preparing protein extracts from head, and as-
saying protein levels with     -Nmnat1 antibodies on Western 
blots. All Wld 
S   variants carry full-length Nmnat1, and thus, this 
antibody should recognize each with equal affi  nity. In some 
cases, each of the three transgenic lines for a given construct 
expressed very similar levels of protein (e.g., N16-Nmnat1 and 
Wld 
S-   N16  ); for others, the total expression level of each protein 
varied among transgenic lines (e.g., Wld 
S  , Nmnat1, Nmnat1 
dead , 
and Wld 
S-dead  ). Despite this fact, the in vivo axon-protective func-
tion of each molecule was in most cases strikingly similar among 
transgenic lines carrying different insertions of the same trans-
gene (see following section). 
  Wallerian degeneration is potently 
suppressed by Wld 
S   and partially blocked 
by Nmnat1, and axonal protection requires 
Nmnat1 enzymatic activity 
  To compare the protective effects of the aforementioned trans-
genes, we crossed each to the ORN-specifi  c driver  OR22a-Gal4 , 
severed ORN axons, and determined the number of remaining 
intact axonal fi  bers present at 5, 10, 15, 20, and 30 d after in-
jury (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200808042/DC1). Each neuroprotective molecule showed 
a unique pattern of protection, but this was indistinguishable 
among the other transgenic lines carrying the same transgene 
(Fig. S2), and therefore, axon protection data were pooled for 
each transgene (  Fig. 3  ). 
 We  fi  rst asked whether Nmnat1 could protect severed 
axons in vivo at a level similar to Wld 
S   and whether Nmnat1 
primary neuronal cultures with NAD 
+   application (  Conforti 
et al., 2007  ). Moreover, transgenic mice expressing Nmnat1 
in neurons failed to phenocopy   Wld 
S     ( Conforti  et  al.,  2007 ). 
Finally, a third model proposes that Nmnat1 acts in the nu-
cleus before injury through Sirt1, a member of the sirtuin fam-
ily of NAD 
+  -binding histone deacetylases, to change patterns 
of neuronal gene expression before injury, which protects sev-
ered axons after axotomy (  Araki et al., 2004  ).   Araki et al. 
(2004)   provided in vitro data in support of this model showing 
that siRNAs directed toward   sirt1   could partially suppress the 
neuroprotective effects of bath-applied NAD 
+  ; however, a null 
allele of   sirt1   failed to suppress the ability of Wld 
S   to protect 
severed axons in vivo (  Wang et al., 2005  ). 
  The aforementioned models remain open possibilities but 
have not been tested incisively in vivo. In this study, we explore 
the in vivo mechanistic action of Wld 
S   in   Drosophila .  We  fi  nd 
that Wld 
S  -mediated protection requires two activities: Nmnat1 
enzymatic function and the N-terminal 16 amino acids of N70 
(termed N16). We show that N16 associates with TER94, the 
fl  y orthologue of the mouse N16-binding molecule valosin-
containing protein (VCP;   Laser et al., 2006  ), and that VCP is 
essential for Wld 
S  -like levels of axon protection. Thus, the 
converging activity of domains derived from both Ube4b and 
Nmnat1 are essential for Wld 
S  -like levels of axon protection in 
vivo. Surprisingly, we fi  nd that Nmnat3, a mouse mitochondrial 
Nmnat that localizes throughout the cytoplasm in   Drosophila  
cells (but not to the nucleus), can protect severed axons as well 
as Wld 
S  . Thus, nuclear localization of Nmnat activity is not 
  essential for robust axon protection, and these data raise the 
  intriguing possibility that N16  –  VCP/Ter94 interactions may 
function to relocalize Nmnat1 outside of the nucleus, perhaps to 
mitochondria, where it exerts its neuroprotective effects. 
  Results 
  Constructs generated for in vivo functional 
dissection of Wld 
S   
  The adult   Drosophila   olfactory system offers an excellent op-
portunity to study Wallerian degeneration and Wld 
S   function in 
a well-controlled in vivo setting: odorant receptor (OR)  –  Gal4 
driver lines can be used to reproducibly label specifi  c subsets of 
axons with membrane-tethered GFP (mCD8-GFP); nonlethal 
surgical ablation of antennae or maxillary palps induces Walle-
rian degeneration of olfactory receptor neuron (ORN) axons; 
severed axon degeneration can be monitored in the intact brain 
for months after injury; and neuroprotective molecules like 
Wld 
S   can be expressed in these axons at standardized levels to 
quantitatively compare neuroprotective activity (  MacDonald 
et al., 2006  ). In this study, we use this system to defi  ne the func-
tional domains in Wld 
S   that are essential for protection of sev-
ered axons in vivo. 
  We constructed several transgenic   Drosophila   lines  carry-
ing variants of the Wld 
S   molecule (  Fig. 1 A  ): (a)   upstream acti-
vating sequence   ( UAS )  – nmnat1  , full-length mouse   nmnat1 ; 
(b)   UAS-nmnat1 
dead    , full-length mouse   nmnat1   with an H24A sub-
stitution, which has been previously shown to allow folding of 
Nmnat and binding of its substrate but largely to abolish sub-JCB • VOLUME 184 • NUMBER 4 • 2009  504
of severed axons in animals expressing Wld 
S   remained intact 
even 30 d after injury (77%), whereas a minority of axons ex-
pressing Nmnat1 (32%) remained intact at this time point. 
Thus, Nmnat1 is indeed a neuroprotective molecule in vivo 
and likely represents an important component of the severed 
axon-protecting activity of Wld 
S . However, the fact that Nmnat1 
provided signifi  cantly reduced protection of severed axons 
compared with Wld 
S   argues that N70 and/or W18 enhances 
the neuroprotective nature of Nmnat1 in important ways to pro-
vide Wld 
S  -like levels of axon protection. 
enzymatic activity was essential for axonal protection. Previ-
ously, we reported that mouse Wld 
S   could robustly suppress 
Wallerian degeneration in   Drosophila   for at least 20 d after in-
jury (  MacDonald et al., 2006  ). We have now confi  rmed and 
extended this fi  nding to 30 d after injury, with the majority 
(77%) of Wld 
S  -expressing axons remaining intact for this pe-
riod (  Fig. 3  ). Interestingly, we found that expression of mouse 
Nmnat1 in ORNs also partially suppressed Wallerian degener-
ation; however, Nmnat1 was signifi  cantly less effective than 
Wld 
S   at protecting severed axons. For example, the majority 
  Figure 2.       Wld 
S   variant proteins are stably expressed in 
  Drosophila   neurons.   Three independent UAS-driven trans-
gene insertion lines for each Wld 
S   variant molecule were 
crossed to   elav-Gal4  , and protein extracts from heads were 
assayed for expression using     -Nmnat1 antibodies. Multiple 
lines for each construct were found to express detectable 
levels of protein. The expression of each of these molecules 
in ORNs with   OR22a-Gal4   did not lead to expression of 
proteins at levels detectable by Western blot analysis (not 
depicted). Molecular masses are shown in kilodaltons. MW, 
molecular weight.     
  Figure 3.       Wld 
S   requires N70 and Nmnat1 
biosynthetic activity for maximal protection of 
severed axons in vivo.   UAS-regulated versions 
of Wld 
S   variants were expressed in OR22a 
+   
ORNs with   OR22a-Gal4  , axons were severed, 
and the number of remaining intact GFP 
+   axons 
was scored at the time points indicated. Two 
to four independent insertion lines were tested 
for each UAS-regulated Wld 
S   variant molecule 
(Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200808042/DC1);   n     ≥   
10 for individual lines; data were subsequently 
pooled and are presented here. For Nmnat1, 
**, P   <   0.01 and ***, P   <   0.001 (Nmnat1 vs. 
Wld 
S   at corresponding time points). For Wld 
S  , 
**, P   <   0.01 (day 0 vs. day 30). Error bars 
represent SEM.     505 IN VIVO FUNCTIONAL DISSECTION OF WLD 
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Wld 
S ,  Wld 
S-   N16   provided signifi  cantly reduced protection of 
severed axons, with 25% and 35% of axons degenerating by day 
10 and day 20 after injury, respectively (  Fig. 4  ). Wld 
S-   N16 -
  mediated protection was indistinguishable from that afforded by 
Nmnat1, suggesting that N16 is the key domain responsible for 
the increased protection we observed in axons expressing Wld 
S  
compared with Nmnat1. Reciprocally, N16-Nmnat1 expression 
in axons provided signifi  cantly increased protection of severed 
axons relative to Nmnat1 alone, with   >  90% of axons surviving 
as long as 20 d after injury (  Fig. 4  ). Therefore, N16-Nmnat1  –
  mediated protection of severed axons was indistinguishable 
from the protection provided by Wld 
S  . In summary, we fi  nd that 
N16 is essential for Wld 
S  -like neuroprotective activity and is 
suffi  cient when tethered to Nmnat1 to provide Wld 
S -like  levels 
of severed axon protection in vivo. Together, the aforemen-
tioned data indicate that Wld 
S  -mediated axon protection results 
from two synergizing activities: (1) Nmnat1 enzymatic activity 
and (2) N16-dependent protein  –  protein interactions. 
  VCP/TER94 binds to N16 and is essential 
for Wld 
S  -like neuroprotection 
  The only protein known to physically interact with Wld 
S   is 
VCP, and it does so through the N16 domain (  Laser et al., 
2006  ), but its role in Wld 
S  -mediated axon protection remains 
unclear. To determine whether   Drosophila   VCP,  known  as 
TER94 (  Pinter et al., 1998  ), associates with mouse Wld 
S ,  we 
transfected  Drosophila  S2 cells with Wld 
S -Myc and performed 
coimmunoprecipitation experiments with    -Myc  antibodies. 
We found that Wld 
S  -Myc was stably expressed in   Drosophila  
S2 cells and localized primarily to the nucleus (  Fig. 5, A and B  ). 
Two isoforms of TER94 are present in   Drosophila ,  one  of  50 
kD (isoform A) and a second of 97 kD (isoform B). We found that 
S2 cells normally express the 50-kD isoform and lower levels 
of the 97-kD isoform. Immunoprecipitations with    -Myc  anti-
bodies from Wld 
S  -Myc  –  transfected S2 cells led to robust co-
purifi  cation of the 97-kD isoform (which is   >  80% identical to 
  Next, we assayed the ability of enzyme-dead variants of 
Wld 
S   and Nmnat1 to protect severed axons. Strikingly, blocking 
the enzymatic activity of Nmnat1 with an H24A mutation al-
most completely eliminated the ability of Nmnat1 to protect sev-
ered axons. In Nmnat1 
dead  -expressing animals,     100% of all 
axons had undergone Wallerian degeneration within 10 d after 
injury (  Fig. 3  ). Thus, Nmnat1-dependent axon protection requires 
the NAD 
+   biosynthetic activity of Nmnat1. Consistent with a 
role for Nmnat1 enzymatic activity in promoting Wld 
S -dependent 
axon protection, we found that Wld 
S-dead   also exhibited strongly 
reduced neuroprotection: in Wld 
S-dead  -expressing animals, 92% 
of axons had degenerated within 15 d after injury (  Fig. 3  ). Inter-
estingly, and in contrast to Nmnat1 
dead ,  Wld 
S-dead   exhibited  inter-
mediate levels of protection until 10 d after injury, indicating 
that Wld 
S-dead   retains a moderate level of axon-sparing activity 
despite having reduced Nmnat1 enzymatic activity. These data 
provide further strong evidence that N70 or W18 domains of 
Wld 
S   are important for Wld 
S  -dependent protection of severed 
axons and indicate that Nmnat1 enzymatic activity is essential 
for sustained Wld 
S  -dependent protection of axons. 
  The N16 domain of Wld 
S   is essential for 
maximal axon protection and accounts for 
differences in neuroprotection observed 
between Wld 
S   and Nmnat1 
  Which portion of N70 or W18 is responsible for the increased 
neuroprotection of Wld 
S   relative to that observed with Nmnat1? 
Previous biochemical experiments identifi  ed N16 as a binding 
site for association of Wld 
S   with VCP (  Laser et al., 2006  ). 
We sought to determine the functional requirements for the N16 
domain in Wld 
S  -mediated protection of severed axons in vivo. 
Therefore, we generated two transgenic constructs, Wld 
S-   N16  
(harboring a specifi  c deletion of the N16 domain) and N16-
Nmnat1 (in which only the N16 domain is directly fused to the 
N terminus of Nmnat1;   Fig. 1 A  ) and assayed axon-protective 
effects. In striking contrast to the protection observed with 
  Figure 4.       N16 is the key domain in the N terminus of Wld 
S   that is essential for Wld 
S  -like axon protection.   Wld 
S  , Nmnat1,     N16-Wld 
S  , and N16-Nmnat1 
were expressed in ORNs using   OR22a-Gal4  , axons were severed, and the number of remaining intact GFP 
+   severed axons were scored at the time points 
indicated.   n     ≥   10 for all genotypes; **, P   <   0.01. Error bars represent SEM.     JCB • VOLUME 184 • NUMBER 4 • 2009  506
observe in Wld 
S  -expressing axons (unpublished data). We were 
unable to assay TER94 function in Wld 
S  -mediated axon protec-
tion in a null TER94 background because animals homozygous 
for strong loss of function alleles of TER94 are homozygous 
lethal (  Ruden et al., 2000  ). Therefore, we turned to RNAi methods 
to knock down TER94 function specifi  cally in Wld 
S -expressing 
axons. Strikingly, we found that knocking down TER94 in 
Wld 
S  -expressing axons with   UAS-TER94 
RNAi     suppressed the axon-
protective function of Wld 
S   to levels indistinguishable from 
Nmnat1 and Wld 
S-   N16   (  Fig. 5 D  ). Uninjured age-matched con-
trols for Wld 
S /TER94 
RNAi   and  TER94 
RNAi   animals were indistin-
guishable from day 0 controls, and thus, the axon loss observed 
in Wld 
S  /TER94 animals was dependent on axotomy. We note 
that RNAi for TER94 alone did result in a slight but signifi  cant 
reduction in the number of axons present in uninjured animals 
in the absence of Wld 
S   (  Fig. 5 D  ), suggesting that TER94 
RNAi  
mouse VCP;   Fig. 5 C  ), indicating that Wld 
S  -Myc can associate 
with TER94. Whether Wld 
S  -Myc associates with the 50-kD 
isoform of TER94 remains unclear because this protein runs at 
the same size as the mouse IgG heavy chain used for Wld 
S -
Myc pull-downs. Thus, TER94, like VCP in mammals, can 
physically associate with Wld 
S   in   Drosophila . 
 Next, we sought to determine whether loss of TER94 func-
tion could suppress the ability of Wld 
S   to protect severed axons. 
Because deletion of N16 from Wld 
S   suppresses the axon-protective 
function of Wld 
S   to levels equivalent to Nmnat1 (  Fig. 4  ), we 
predicted that blocking TER94 function in Wld 
S -expressing 
neurons should phenocopy the protective effects of Nmnat1 
and Wld 
S-   N16 .  We  fi  rst assayed whether null alleles of TER94 
could dominantly suppress the ability of Wld 
S   to protect severed 
axons, but Wld 
S  -expressing animals lacking a single copy of 
TER94 showed the normally high levels of axon protection we 
  Figure 5.       Wld 
S   localizes to the nucleus in   Drosophila   S2 cells and associates with TER94, and TER94 is essential for Wld 
S  -like levels of axon protection.   
(A and B) S2 cells were transfected with Wld 
S  -myc and stained with     -Myc antibodies, and     -Myc immunoreactivity localized to the nucleus. (C) Immuno-
precipitation (IP) from Wld 
S  -Myc  –  transfected cell lysates with     -Myc antibodies led to the puriﬁ  cation of a 97-kD isoform of Ter94. HC, heavy chain from 
    -Myc IgG; WB, Western blot. (D)   UAS-Ter94 
RNAi     was driven in OR22a 
+   ORNs in the presence or absence of Wld 
S  .   n     ≥   10 for all genotypes; *, P   <   0.05; 
**, P   <   0.01; ***, P   <   0.001. Error bars represent SEM. Bar, 13.56   μ  m.     507 IN VIVO FUNCTIONAL DISSECTION OF WLD 
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 In   Drosophila  , there is a single gene that bears strong se-
quence similarity to the mammalian sirtuins,   Sir2  ; Sir2 is 55.9% 
identical to the Sirt1 at the amino acid level. The simplicity of 
the   Drosophila   sirtuin family offers the opportunity to directly 
reassess the requirements for sirtuins in Wld 
S   function in vivo. 
We fi rst assayed the requirements for   Drosophila Sir2   in  Wld 
S -
mediated protection of severed axons using a UAS-regulated 
RNAi construct targeted to   Sir2  . We found that expression of 
  Sir2 
RNAi     in axons did not induce spontaneous degeneration and 
that ORN axons appeared to develop normally (unpublished 
data). Axotomized   Sir2 
RNAi    -expressing axons exhibited normal 
axon degeneration, arguing that Sir2 function is not required 
for Wallerian degeneration (  Fig. 6 A  ). Moreover, expression of 
  Sir2 
RNAi     in Wld 
S  -expressing axons did not suppress the ability of 
Wld 
S   to protect severed axons (  Fig. 6 A  ). Next, we confi  rmed 
our observation with   Sir2 
RNAi     genetically by crossing Wld 
S   into 
a   Sir2  -null mutant background. Loss of function alleles of   Sir2  
are not available; however, removal of the   Sir2   gene can be 
can induce low level axon degeneration. However, the vast ma-
jority of axons in these animals were intact before injury and 
in age-matched controls, indicating that TER94 
RNAi   treatment 
does not cause widespread degeneration of axons on its own. 
In summary, we conclude that TER94 is autonomously required 
in Wld 
S  -expressing neurons in vivo for Wld 
S   to maximally protect 
severed axons from autodestruction. Furthermore, we propose 
that the key neuroprotective portion of the N70/W18 domain of 
Wld 
S   is N16 and that its neuroprotective effects are mediated by 
a TER94/VCP-dependent mechanism. 
  A major cellular role for TER94/VCP is targeting proteins 
for refolding, or destruction as part of the UPS degradation 
pathway. TER94/VCP sits at a pivotal point in the cascade, hav-
ing the ability to direct refolding or degradation of substrates 
based on its binding partners. When associated with ubiqui-
tinated proteins, VCP can either bind Npl4 and Ufd2 and target 
proteins for proteasomal degradation or bind Ufd1 and Plap 
and release refolded proteins into the cytoplasm (for review see 
  Halawani and Latterich, 2006  ). In an attempt to identify addi-
tional molecules that interact with TER94/VCP to modulate 
axon autodestruction or Wld 
S  -mediated neuroprotection, we 
  assayed the requirements of the following   Drosophila   genes in 
Wallerian degeneration and Wld 
S   function:   CG4673 ,  encoding 
the   Drosophila   orthologue of   npl4 ;   ufd2 ;   ufd1 -like;  and   plap , 
encoding the   Drosophila   orthologue of Ufd3. For each mole-
cule, we used UAS-regulated RNAi constructs to knock down 
their function in neurons and assayed the ability of these mole-
cules to (a) induce spontaneous axon degeneration, (b) suppress 
axon autodestruction 15 d after injury, and (c) suppress the abil-
ity of Wld 
S   to protect severed axons. We found that knockdown 
of each of these genes failed to dramatically suppress normal 
axon development, axon stability, degeneration after axotomy, 
or the ability of Wld 
S   to protect severed axons (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200808042/DC1). 
These data argue that additional components of the TER94/VCP 
complex are not involved in Wallerian degeneration or Wld 
S -
mediated protection of severed axons. 
  A lack of evidence for a requirement 
for Sir2 function in Wld 
S  -mediated 
axon protection 
  Sirt1, a member of the mammalian family of Sir2-like NAD 
+ -
binding histone deacetylases (the sirtuins), has been implicated in 
NAD 
+  -mediated axon protection through a lentiviral-expressing 
siRNA study in mammalian tissue culture. Specifi  cally, siRNA 
knockdown of Sirt1, but not the six other mammalian sirtuins 
(Sirt2  –  7), partially suppressed the ability of NAD 
+   application 
to protect axons in dorsal root ganglion explant cultures (  Araki 
et al., 2004  ). Surprisingly, in a subsequent study in which a 
  sirt1  -null mutation was crossed into the   Wld 
S     background,  loss 
of   sirt1   failed to suppress the ability of Wld 
S   to protect severed 
axons in vivo (  Wang et al., 2005  ), calling into question the role 
of Sirt1 in executing Wld 
S   function. Importantly, it remains an 
open possibility that the remaining mammalian sirtuins (Sirt2  –  7) 
might functionally compensate for Sirt1 in this context, and thus, 
the functional requirements for mammalian sirtuins in Wld 
S  
function remain unclear. 
  Figure 6.       Sir2 is not required for Wld 
S  -mediated protection of severed 
axons, and membrane-tethered Wld 
S   fails to suppress axon degeneration.   
(A)   UAS-Sir2 
RNAi     was driven in OR22a 
+   ORNs with   OR22a-Gal4   in the 
presence or absence of Wld 
S  , and axons were assayed 15 d after injury. 
(B) The requirements for Sir2 in Wld 
S  -mediated axon protection were as-
sayed 15 d after injury in Wld 
S  -expressing axons and Wld 
S   axons that 
lacked   sir2   (  sir2 
4.5  /sir2 
5.26    ).   Wld 
S    ,   n   = 10;   Sir2 
    /        +   Wld 
S    ,   n   = 6. Error 
bars represent SEM.     JCB • VOLUME 184 • NUMBER 4 • 2009  508
of severed axons, that membrane-tethered Wld 
S   is not suffi  cient 
to protect axons, and that Nmnat3, an enzyme that localizes pri-
marily to mitochondria in mammalian cells, provides Wld 
S -like 
levels of axon protection. Thus, nuclear localization appears to 
be nonessential for Wld 
S  -like axon protection, and Nmnat3 and 
Wld 
S   appear to have unique activities or localizations relative to 
Nmnat2 and mCD8-Wld 
S   that allow for robust axon-protective 
function in vivo. 
  Discussion 
  The enzymatic activity of Nmnat1 is a 
critical feature of Wld 
S   
  Whether Nmnat1 and its enzymatic product NAD 
+   underlie the 
protective activity of Wld 
S   has remained a point of great contro-
versy. Two studies found that transfection of   nmnat1   into dorsal 
root ganglia neurons or direct application of NAD 
+   or its bio-
synthetic precursors to dorsal root ganglia cultures was suffi  -
cient to prolong the survival of severed axons in vitro (  Araki 
et al., 2004  ;   Wang et al., 2005  ). In contrast, a subsequent study 
reported a lack of protection of axons by direct expression of 
Nmnat1 in neurons or application of NAD 
+   in vitro, and trans-
genic mice expressing Nmnat1 failed to exhibit signifi  cant in-
creased axon protection in vivo (  Conforti et al., 2007  ). We fi  nd 
that expression of Nmnat1 in   Drosophila   axons provides signif-
icant levels of protection for severed axons, with the majority of 
axons surviving for longer than 2 wk. Thus, Nmnat1 is indeed 
strongly neuroprotective on its own, although the levels of pro-
tection provided by Nmnat1 are signifi  cantly reduced compared 
with Wld 
S  . This observation argues that Nmnat1 is a critical 
component of Wld 
S   but indicates that the protection afforded by 
Wld 
S   and Nmnat1 is not equivalent. As discussed in the follow-
ing section, we propose that the increased effi  ciency of protec-
tion provided by Wld 
S   maps to the N16 domain of Wld 
S ,  which 
interacts with VCP/TER94. Why doesn  ’  t Nmnat1 protect sev-
ered axons in transgenic mice? We can think of at least two ex-
planations for the difference observed between mice and fl  ies 
with respect to in vivo axon protection by Nmnat1. First, we ex-
press   nmnat1   in   Drosophila   using the Gal4/UAS binary expres-
sion system, which can drive very high levels of expression 
in ORN neurons. It is possible that we have increased the rela-
tive amount of Nmnat1 in neurons to a point exceeding that 
necessary for Nmnat1-dependent protection of severed axons, 
whereas expression levels of Nmnat1 in mouse sciatic nerve 
using the     -actin promoter (  Conforti et al., 2007  ) remain below 
this critical threshold. Second, the axons of   Drosophila   ORNs 
are much shorter than mammalian axons in the sciatic nerve and 
may thus be more easily protected relative to lengthy mamma-
lian axons. 
  The protection of severed axons by Nmnat1 critically de-
pends on its enzymatic activity. To generate an Nmnat1 mole-
cule that fails to synthesize NAD 
+  , we engineered an H24A 
substitution in Nmnat1. Based on analysis of the crystal struc-
ture of   Methanobacterium thermoautotrophicum   NMNAT, the 
corresponding histidine (H19) resides in the binding site for 
ATP. Mutational analysis of the importance of this histidine 
with an H19A substitution demonstrated that mutation of this 
 accomplished using a heteroallelic combination of the two partially 
overlapping deletions in   sir2 
5.26     and   sir2 
4.5     mutants  ( Newman 
et al., 2002  ). As with our   Sir2 
RNAi     experiments, we found that 
deletion of the   Sir2   gene in a Wld 
S   background failed to sup-
press the ability of Wld 
S   to protect severed axons from degener-
ation (  Fig. 6 B  ). These data argue strongly that Wld 
S   does not 
require the NAD 
+  -binding histone deacetylase Sir2 to protect 
severed axons from autodestruction. 
  Wallerian degeneration is strongly 
suppressed by mouse mitochondrial 
Nmnat3, but NAD 
+   synthase (NADS), 
membrane-tethered Wld 
S  , and cytoplasmic 
Nmnat2 fail to protect severed axons 
  Do all NAD 
+   biosynthetic enzymes protect axons from auto-
destruction? The   Drosophila   genome encodes one additional 
NAD 
+   biosynthetic enzyme called NADS that by primary se-
quence is not related to Nmnat and in yeast localizes throughout 
the cell (  Suda et al., 2003  ). We generated transgenic fl  ies carrying 
a   UAS-NADS   construct, drove expression in ORN axons as de-
scribed in the fi  rst section of Results, and assayed axon-protective 
function 5 d after injury (  Fig. 7 A  ). Surprisingly, NADS pro-
vided no protection of axons. To determine whether NADS 
might require VCP/TER94 interactions through N16 for detect-
able axon-protective activity, we also generated fl  ies bearing an 
N16-NADS fusion protein but found that this molecule also 
completely failed to suppress axon autodestruction (  Fig. 7 A  ). 
 Wld 
S   is normally localized in the nucleus, but can Wld 
S  
protect severed axons from degeneration if it is forced to local-
ize elsewhere in the cell? We used two approaches to address 
this question. First, we generated a membrane-tethered version 
of Wld 
S  . In brief, we fused the extracellular and transmembrane 
domains of the mouse CD8 surface receptor (  Lee and Luo, 
2001  ) to the N terminus of Wld 
S   (termed mCD8-Wld 
S )  and 
drove the expression of this molecule in 22a 
+   axons. We found 
that adult ORNs stably expressed high levels of mCD8-Wld 
S  
in the axonal compartment (  Fig. 7 B  ). However, we found that 
mCD8-Wld 
S   completely failed to suppress the degeneration of 
severed axons; 10 d after axotomy, 100% of mCD8-Wld 
S+  axons 
degenerated and were cleared from the central nervous system 
(  Fig. 7 C  ). Thus, tethering Wld 
S   to the cell surface in vivo is suf-
fi  cient to block the ability of Wld 
S   to protect severed axons. 
  As a second approach, we assayed the protective func-
tion of mammalian Nmnat molecules that show unique pat-
terns of subcellular localization. In mammals, there are three 
genes encoding Nmnat molecules: Nmnat1, which, as described 
in the fi  rst section of Results, localizes to the nucleus; Nmnat2, 
which is cytoplasmic; and Nmnat3, which localizes primarily 
to mitochondria (  Sasaki et al., 2006  ). Nmnat2 localized to the 
cytoplasm in   Drosophila   S2 cells (  Fig. 7 E  ) but completely 
failed to suppress axon degeneration (  Fig. 7 D  ). In striking 
contrast, Nmnat3, which also appeared to localize largely to 
the cytoplasm in S2 cells (  Fig. 7 E  ), provided levels of axon 
protection that were indistinguishable from those afforded by 
Wld 
S   ( Fig.  7  D ). 
  In summary, these data indicate that only a subset of 
NAD 
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  Figure 7.       Axon-protective function of NAD 
+  -
producing enzymes is speciﬁ  c to Nmnat1 and -3, 
and Nmnat3 protects as well as Wld 
S  .   (A) NADS 
and N16-NADS were expressed in ORNs using 
  OR22a-Gal4  , and axons were severed and ana-
lyzed for protection 5 d after axotomy. (B) Local-
ization of mCD8-Wld 
S   was assayed using     -CD8 
antibodies, and expression of mCD8-Wld 
S   was driven 
in ORNs using the   OR22a-Gal4   driver. Axons are 
indicated projecting to glomeruli (arrowhead) and 
across the midline (arrow), and OR22a 
+   ORN-
innervated glomeruli are shown with dashed lines. 
(C) Membrane-tethered Wld 
S   (mCD8-Wld 
S  ) was 
assayed for axon-protective function 10 d after 
axotomy.   n     ≥   10 for all genotypes. (D) Nmnat2 
and -3 were driven by   OR22a-Gal4   in ORNs to 
assay for protective function 5 d after axotomy. 
  n     ≥   10 for all genotypes; **, P   <   0.01; ***, P   <   
0.001. (E) S2 cells were transfected with Nmnat2-
myc and Nmnat3-myc and stained with     -myc. In 
both cases,     -myc immunoreactivity was localized 
to the cytoplasm but not the nucleus. DIC, differ-
ential interference contrast. Error bars represent 
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(termed N16) have recently been shown to bind VCP/p97 (  Laser 
et al., 2006  ). Through N16, Wld 
S   can redistribute VCP into the 
nucleus (  Dai and Li, 2001  ). VCP, in turn, could result in the 
association of Wld 
S   with a variety of cellular proteins be-
cause VCP is capable of binding an array of oligonucleotide-
ubiquitinated proteins or misfolded proteins and can act to drive 
their polyubiquitination and proteasomal degradation or, alterna-
tively, deubiquitination and release of refolded proteins into the 
cytoplasm (for review see   Halawani and Latterich, 2006  ). Con-
sistent with a VCP-dependent recruitment of polyubiquitinated 
proteins to Wld 
S ,     -ubiquitin immunoreactivity appears to be 
enriched with Wld 
S   in the nucleus in vitro (  Laser et al., 2006  ). 
  The aforementioned data provide an exciting link between 
Wld 
S   and VCP/polyubiquitin, but a requirement for Wld 
S  – VCP 
interactions or N16 in vivo in protecting severed axons has not 
been demonstrated. In this study, we have shown that (a) dele-
tion of the VCP-binding domain N16 from Wld 
S   reduces the 
axon-protective ability of Wld 
S   to levels indistinguishable from 
Nmnat1; (b) tethering N16 to Nmnat1 is suffi  cient to provide 
levels of axon protection equivalent to those observed with 
Wld 
S ;  (c)  Wld 
S   associates with   Drosophila   TER94, the fl  y or-
thologue of VCP; and (d) knocking down TER94 function in 
Wld 
S  -expressing neurons suppresses the axon-protective effects 
of Wld 
S   to levels indistinguishable from those observed with 
Nmnat1. Together, these data argue strongly for a role for N16  –
  VCP interactions and VCP function in mediating the ability of 
Wld 
S   to protect severed axons. 
  How do N16  –  VCP interactions help Wld 
S   protect axons? A 
simple model is that N16  –  VCP interactions function to redistrib-
ute nuclear Nmnat1 activity in the cell to a compartment in which 
its axon-protective effect is maximal. As discussed in the follow-
ing section, an interesting possibility is that this redistribution 
mimics the localization of Nmnat3 (a mitochondrial Nmnat), 
which appears to protect   Drosophila   axons in vivo at a level in-
distinguishable from Wld 
S . Alternatively, N16 may bring Nmnat1 
together with VCP-associating proteins that mediate protective 
effects. For example, perhaps VCP/TER94 binds an unidentifi  ed 
ubiquitinated protein that promotes axon destruction. Because 
Wld 
S   redistributes VCP/TER94 to the nucleus, this molecule 
would in turn be titrated out of axons. This effect, combined with 
the NAD 
+   biosynthetic capacity of Nmnat1, which is partially 
neuroprotective on its own, could combine for robust protection 
of axons. Alternatively, VCP/TER94 may bring a polyubiqui-
tinated NAD 
+  -sensitive molecule into close proximity with 
Nmnat1, which in turn promotes robust axon protection. Identi-
fi  ed VCP-binding proteins that mediate refolding versus degrada-
tive outputs of the VCP complex may not be involved in protecting 
the axons of Wld 
S  -expressing neurons. We assayed the ability of 
several VCP-interacting molecules that are essential to promote 
proteasomal degradation of polyubiquitinated proteins (Ufd2 and 
Npl4/CG4673) or refolding and cytoplasmic release of misfolded 
proteins (Ufd1-like and Plap). Knockdown of these molecules in 
neurons failed to induce widespread spontaneous axon degenera-
tion, suppress axon degeneration after axotomy, or reduce the 
ability of Wld 
S   to protect severed axons. Although we cannot ex-
clude the possibility that RNAi knockdown of these molecules 
was incomplete, these data begin to argue that VCP/TER94 
residue reduced NAD 
+   biosynthetic activity to   <  1%, did not 
 signifi  cantly affect protein folding (determined by solving the 
crystal structure of the H19A mutant version), and led to the 
 copurifi   cation of NMNAT with its substrate nicotinamide 
mononucleotide trapped in the active site rather than its product 
NAD 
+  , which copurifi  es with wild-type NMNAT (  Saridakis 
et al., 2001  ). This suggests a failure of NMNAT to convert nico-
tinamide mononucleotide to NAD 
+ .  We  fi  nd that an H24A substi-
tution in Nmnat1 completely suppresses the neuroprotective effects 
of Nmnat1, with close to 100% of the axons from Nmnat1 
dead -
expressing neurons degenerating within 5 d after injury. Wld 
S-dead , 
harboring the same H24A mutation in Nmnat1, also shows dra-
matically reduced effi  cacy in the protection of severed axons. 
Together, these data demonstrate a requirement for Nmnat1 
enzymatic activity in Wld 
S  -mediated protection of severed 
axons in vivo. In turn, along with the aforementioned studies, 
they suggest that the effects of Nmnat1 are mediated by its bio-
synthetic products. NAD 
+   is certainly the best-known product 
of Nmnat1 enzymatic activity and likely plays a key role in axon 
protection; however, we note that we cannot exclude the formal 
possibility that in the context of axon protection, Nmnat1 may 
generate additional biosynthetic products beyond NAD 
+   that 
might be neuroprotective. 
 Interestingly, recent work on  Drosophila  Nmnat (dNmnat) 
has revealed a role for dNmnat1 in the suppression of activity- or 
spinocerebellar ataxia 1 (Sca1)  –  induced degeneration in the visual 
system (  Zhai et al., 2006, 2008  ). Surprisingly, the dNmnat-
  dependent protection of neurons in the visual system is inde-
pendent of its enzymatic activity, and dNmnat appears capable 
of acting as a chaperone-like molecule in an enzymatic activity  –
  independent manner (  Zhai et al., 2008  ). Is this chaperone-like 
activity contributing to Wld 
S -dependent  neuroprotection?  Al-
though this remains an open possibility, we suspect it is not a 
major contributing force in the mechanistic action of Wld 
S   in 
severed axons for two reasons. First, Wld 
S   and Nmnat1 both 
  require their enzymatic activity to protect severed axons in vivo, 
whereas dNmnat can protect against Sca1-induced neuro-
degeneration in the absence of enzyme function. Second, dNmnat 
is induced in response to the formation of Sca1 aggregates and 
localizes to sites of protein aggregation, whereas Wld 
S   and 
Nmnat1 show no such localization. A more thorough delinea-
tion of the mechanistic action of Wld 
S  , Nmnat1, and dNmnat 
will be essential to resolve these issues. 
  N70 contributes to Wld 
S   neuroprotective 
function through interactions with 
VCP/TER94 
  How N70 or W18 could contribute to Wld 
S   function has re-
mained enigmatic. The portion of Ube4b found in Wld 
S ,  N70, 
lacks the U box found in Ube4b that is essential for E4 ubiqui-
tination activity (  Hatakeyama et al., 2001  ;   Hatakeyama and 
Nakayama, 2003  ) and thus does not have ubiquitin-conjugating 
activity on its own. However, a deletion study of Ube4b has 
shown that this N-terminal domain is indeed essential for Ube4b 
ubiquitination activity ( Mahoney et al., 2002 ). Although specifi  c 
domains necessary for ubiquitination activity of mouse Ube4b 
have not been identifi  ed in N70, the fi  rst 16 amino acids of N70 511 IN VIVO FUNCTIONAL DISSECTION OF WLD 
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ization, protein  –  protein interactions, or enzymatic activity, 
which results in axon-protective activity; (b) the fact that multi-
ple NAD 
+   biosynthetic enzymes protect severed axons may indi-
cate that changes in NAD 
+   are a key factor in suppression of 
Wallerian degeneration; (c) Nmnat3 is not expected to bind 
VCP/TER94 but can protect axons at levels equivalent to Wld 
S ; 
thus, N16  –  VCP interactions do not appear to be essential for 
Wld 
S -like neuroprotection by Nmnat molecules; and (d) Nmnat3 
localizes outside the nucleus in   Drosophila   and mammals, argu-
ing that nuclear localization of Nmnat activity is not essential for 
robust axon protection. Interestingly, it was recently found that 
Nmnat1 and Nmnat3 can also suppress degeneration induced by 
rotenone, an activator of mitochondrial oxidative stress (  Press 
and Milbrandt, 2008  ). This observation, coupled with the robust 
protection of axons we observe with Nmnat3, may point to a role 
for Wld 
S  /Nmnat activity in mitochondria for axon protection. In 
the future, it will be critical to defi  ne the site of action of Wld 
S  
and Nmnat3 and determine whether they are protecting axons by 
similar mechanisms. 
 The   Wld 
S     mutation protects axons through gain of func-
tion mechanisms. Is Wld 
S   telling us that axons initiate an active 
axon autodestruction pathway akin to cell death, as has been 
previously speculated (  Coleman and Perry, 2002  ;   Raff et al., 
2002 ),  or  is  Wld 
S   an aberration that fortuitously blocks Walle-
rian degeneration? Based on work in other invertebrates, we 
favor the notion that axons in mice,   Drosophila  , and many other 
species indeed initiate an active process of autodestruction after 
axotomy. A considerable literature exists supporting the ability 
of severed axons in both vertebrates and invertebrates to exhibit 
long-term survival (  Bittner, 1991  ). A striking example comes from 
two species of crickets,   Teleogryllus commodus   and   Gryllus  
  bimaculatus  . In these animals, behavioral rhythmicity is gov-
erned by a small number of pigment-dispersing factor  –  positive 
neurons whose cell bodies reside in the optic lobes. The removal 
of cell bodies fails to induce degeneration of severed pigment-
dispersing factor  –  positive axons, which can survive for up to 
90 d after axotomy, and, impressively, behaviors subject to cir-
cadian control remain robust, indicating that severed surviving 
axonal stumps remain functionally intact for many weeks after 
axotomy (  Stengl, 1995  ). Why some axons spontaneously de-
generate after injury whereas others do not is unknown, but de-
fi  ning the molecular pathways that account for these striking 
differences in the axonal survival and precisely how Wld 
S   im-
pinges upon these pathways will be an extremely important 
  future goal to further our understanding of the basic cellular 
mechanisms by which neurons maintain the functional integrity 
of axons. Our fi  ndings point to the importance of defi  ning mole-
cules downstream of Wld 
S  , perhaps outside the nucleus, that in-
teract with VCP or NAD 
+  , and we suggest that these will be key 
modulators of Wallerian degeneration. 
  Materials and methods 
    Drosophila   stocks and transgenics 
  The following stocks were used:   OR22a-Gal4   (a gift from J. Carlson, Yale 
University, New Haven, CT);   pUAST-mCD8–GFP  ,   GH146-Gal4  , and   elav-
Gal4   (a gift from T. Lee, University of Massachusetts Medical School, 
Worcester, MA);   Sir2 
4.5     and   Sir2 
5.26     (a gift from S. Smolik, Oregon Health 
interactions with N16 do not require these molecules for the exe-
cution of Wld 
S  -mediated axon protection. Further work aimed at 
defi  ning the site of action of Wld 
S   and identifying molecules in-
teracting with Wld 
S    –  VCP/TER94 complexes in vivo will be es-
sential to clarify these issues. 
  Finally, we note that we have defi  ned the minimal domains 
essential for Wld 
S  -like levels of neuroprotection as N16-Nmnat1. 
W18 is not normally a domain found in any mouse protein, being 
generated by the spontaneous fusion event in   Wld 
S     mice, but a 
role for this domain in axon protection remained an open possi-
bility. The deletion of amino acids 17  –  70 of N70 and W18 in the 
N16-Nmnat1 construct demonstrates that these domains are dis-
pensable for Wld 
S  -mediated axon protection. 
  Severed axon autodestruction: the role of 
nuclear Wld 
S  , NAD 
+  , and Nmnat activity 
  The strong localization of Wld 
S   to the nucleus in mice and 
  Drosophila   provides a compelling argument for a nuclear role for 
Wld 
S   in protecting severed axons. Impressively, even expression 
of high levels of Wld 
S   in fl  y neurons with the Gal4/UAS binary 
system failed to result in detectable axonal localization of Wld 
S -
Myc in vivo. Despite its clear localization to the nucleus, it has 
remained unclear whether nuclear localization is essential for 
Wld 
S   to protect severed axons or whether its presence in the nu-
cleus points to an underlying role in modifying gene expression 
patterns and thereby axon stability. A role for the NAD 
+ -binding 
histone deacetylase Sirt1 in Wld 
S  -mediated axon protection 
seems increasingly unlikely; previous work has shown that 
crossing null alleles of   Sirt1   into  the  Wld 
S   background fails to 
suppress the ability of Wld 
S   to protect axons (  Wang et al., 2005  ), 
and we show that loss of the   Drosophila   orthologue of Sirt1, 
Sir2, does not affect the ability of Wld 
S   to protect severed axons 
in vivo. Interestingly, we found that tethering Wld 
S   to the mem-
brane by fusing it with mCD8 completely suppressed the ability 
of Wld 
S   to protect severed axons; therefore, the presence of 
membrane-tethered (likely) monomers of Wld 
S   is insuffi  cient 
for any level of axon protection, suggesting that localization or 
free solubility of Wld 
S   is important to its function. 
  Are changes in NAD 
+   production responsible for the axon-
protective effects of Wld 
S  ? To further explore the role of NAD 
+  
biosynthesis in suppressing axon autodestruction, we assayed 
the ability of various   Drosophila   and mammalian NAD 
+   bio-
synthetic enzymes to block Wallerian degeneration. Surprisingly, 
of the four NAD 
+   biosynthetic molecules we tested, only two, 
Nmnat1 and Nmnat3, protected severed axons from autodestruc-
tion. Nmnat2, which localizes to the cytoplasm in mammalian 
and   Drosophila   cells, exhibited no protective effect. Likewise, 
NADS, an NAD 
+   biosynthetic molecule that generates NAD 
+  
from a different pool of precursors than Nmnat (  Rongvaux et al., 
2003  ), failed to protect severed axons from degeneration. 
In striking contrast, Nmnat3, which localizes to mitochondria in 
mammals and throughout the cytoplasm in   Drosophila   cells, 
provided robust protection of axons at levels indistinguishable 
from those afforded by Wld 
S   5 d after injury. These observations 
raise several important points: (a) not all NAD 
+   biosynthetic  en-
zymes are capable of suppressing Wallerian degeneration, which 
argues that Nmnat1 and Nmnat3 are somehow unique in local-JCB • VOLUME 184 • NUMBER 4 • 2009  512
third antennal segments were surgically ablated with tweezers, and the 
ﬂ  ies were kept at 25  °  C until dissection (5, 10, 15, 20, or 30 d), as indi-
cated in   Figs. 3  –  7   and Figs. S2 and S3. Uninjured ﬂ  ies were dissected 
1 wk after eclosion unless denoted in legends as age matched. Adult 
heads were ﬁ  xed with 4% formaldehyde (Sigma-Aldrich) in 1  ×   PBS and 
0.1% Triton X-100 (PTx; Sigma-Aldrich) for 20 min before dissection and 
washed ﬁ  ve times with PTx. Dissected brains were subsequently ﬁ  xed in 
4% formaldehyde in PTx for 10 min and washed ﬁ  ve times with PTx and 
three times with 1  ×   PBS/0.1% Triton X-100/1% BSA (PBT; Thermo Fisher 
Scientiﬁ  c). Brains were rocked for 30 min in PBT at room temperature, 
and primary antibodies were added in PBT and rocked overnight at 4  °  C. 
Brains were washed 10 times over 1.5 h with PBT, and secondary anti-
bodies were added in PBT. Brains were rocked for 3 h in secondary anti-
body at room temperature and subsequently washed 10 times over 1.5 h 
with PBT. Brains were stored at 4  °  C in antifade reagent (Bio-Rad Labora-
tories). In the case of animals expressing GFP, no antibodies were used 
to enhance the GFP signal. 
  Immunolabeling, confocal microscopy, and quantiﬁ  cation of 
axon protection 
  Standard methods were used for dissection, ﬁ  xation, and antibody label-
ing of the   Drosophila   adult brain (  MacDonald et al., 2006  ). Primary anti-
bodies were used at the following dilutions: 1:1,000 for immunolabeling 
of mouse tissue with     -Myc (9E10; Covance), 1:500 for Western blot analy-
sis of     -VCP (BD), and 1:250 for rabbit     -Nmnat1 (a gift from M. Cole-
man, Babraham Institute, Cambridge, England, UK). Secondary antibodies 
(Cy3; Jackson ImmunoResearch Laboratories) for immunolabeling of tissues 
were used at 1:200. Specimens were mounted in a 1:1 mixture of antifade 
reagent and 75% glycerol. Confocal z stacks of antennal lobes and S2 
cells were collected on a confocal microscope (Axioskop2 LSM 5 Pascal; 
Carl Zeiss, Inc.) with a Plan Apochromat 63  ×   NA 1.4 objective lens (Carl 
Zeiss, Inc.), which was also equipped with a transmitted light detector used 
for acquisition of differential interference contrast images of S2 cells. All 
confocal microscopy was performed at room temperature (21  °  C) using ac-
quisition software (LSM 5 Pascal; Carl Zeiss, Inc.). Confocal images were 
compressed with ImageJ software (National Institutes of Health), and intact 
GFP 
+   axons were counted individually at the indicated time points. At least 
two lines (in most cases three to four) were assayed for each construct, re-
sults among lines carrying the same construct were indistinguishable from 
one another, and data were subsequently pooled. 
  Immunoprecipitations from S2 cell extracts 
    Drosophila   S2 cells were counted and plated at 1   ×   10 
6   cells/ml, incu-
bated overnight at 30  °  C, transfected with   pUAST-Wld 
S  –myc   and   pAC-
Gal4   according to the instructions in the Transfectene kit (QIAGEN), and 
incubated for 48 h. Protein G  –  Sepharose fast-ﬂ  ow beads (GE Healthcare) 
were washed in extraction buffer (150 mM NaCl, 1% Igepal CA630, 
50 mM Tris, pH 7.5, and 1  ×   EDTA-free complete protease inhibitor) and 
bound with     -Myc antibody for 3 h at 4  °  C. Transfected and untransfected 
cells were isolated and centrifuged at 3,000 rpm for 5 min at 4  °  C. Cells 
were resuspended in extraction buffer and placed in ethanol/dry ice bath 
for 5 min, thawed in a cold ice bath, homogenized, and centrifuged at 
11,000 rpm for 10 min at 4  °  C. A fraction of the supernatant was reserved as 
input, and remaining samples were precleared with equilibrated protein G  –
  Sepharose beads for 2 h at 4  °  C, added to     -myc  –  conjugated protein G  –
  Sepharose beads, and incubated at 4  °  C overnight. The samples were then 
centrifuged at 2,000 rpm for 1 min. A portion of the supernatant was re-
served as the ﬂ  ow-through sample, and the remaining supernatant was dis-
carded; beads were washed ﬁ  ve times with extraction buffer, and bound 
protein was eluted from beads with SDS-PAGE loading buffer. 
  S2 cell transfection and immunolabeling 
    Drosophila   S2 cells were counted and plated at 1   ×   10 
6   cells/ml, incu-
bated overnight at 30  °  C, and transfected with   pUAST-Wld 
S  –myc   and 
  pAC-Gal4   according to the instructions in the Transfectene kit. Cells 
were then ﬁ  xed in PEM (Pipes, EGTA, and MgCl  2   buffer)/4% formalde-
hyde and washed with PBT. Primary antibody (    -myc) was added to the 
cells at 1:1,000, cells were washed, and secondary     -mouse anti-
bodies were added at 1:200. Immunolabeling was then viewed with 
confocal microscopy. 
  Online supplemental material 
  Fig. S1 shows how the quantiﬁ  cation of intact axons was counted. Fig. S2 
compares the various transgenes of each construct to show that expres-
sion level variations did not affect the protection level. Fig. S3 shows 
and Science University, Portland, Oregon);   UAS-Ter94 
RNAi    ,   UAS-CG4673 
RNAi    , 
  UAS-CG9934 
RNAi    ,   UAS-Plap 
RNAi    , and   UAS-Ufd1  –  like 
RNAi     (Vienna Drosoph-
ila RNAi Center); and   UAS-Sir2-RNAi   (National Institute of Genetics 
Stock Center). 
    pUAST-Wld 
S  –myc   was created by PCR amplifying a 1.1-kb fragment 
from   pUAST-Wld 
S     and fusing six tandem Myc tags onto the C terminus 
of   Wld 
S     using the primers 5    -  GATCAGATCTCAAAACATGGAGGAGCT-
GAGCGCTGAC-3       and 5    -  ATAATCCGCGGCAGAGTGGAATGGTTGT-
GCTTG-3       and subsequently subcloning this fragment into pUAST with 
BglII and SacII.   pUAST-Nmnat1   was created by subcloning mouse   nmnat1   
(858 bp from   Mus musculus  ) from pHSVPrPUC (a gift from Z. He, Harvard 
University, Cambridge, MA) into pBluescript-KS with BamHI and EcoRI. It 
was then subcloned from pBluescript-KS into pUAST with BamHI and XhoI 
cut sites and was subsequently subcloned into pUAST using BglII and XhoI 
cut sites.   Nmnat1 
dead     was subcloned in the same manner but carries the 
H24A mutation (a gift from Z. He). 
    pUAST-Wld 
S-dead     was created by subcloning   Wld 
S     from pUAST 
(a gift from L. Luo, Stanford University, Stanford, CA) to pBluescript-KS 
using EcoRI and XbaI, and then a 245-bp C-terminal fragment including the 
H24A mutation was used to replace the corresponding region of   nmnat1  . 
The resulting 1.1-kb fragment (  Wld 
S-dead    ) was then subcloned from pBlue-
script-KS into pUAST.   pUAST-Wld 
S-    N16     was created by cloning amino 
acids 17  –  373 of   Wld 
S     into pUAST with BglII and XhoI and adding a 
5     Met-encoding codon using the primers 5    -GATCAGATCTCAAAACAT-
GCTTGCTGGTGGACAGACCTCCC-3     and 5    -TATACTCGAGTCACAGA-
GTGGAATGGTTGTGCTTGGCC-3    . 
    pUAST-N16–nmnat1   was created by subcloning   N16   into pUAST 
and subsequently amplifying an 850-bp fragment of   M. musculus nmnat1   
using the primers 5    -  GAATGCTAGCATGGACTCATCCAAGAAGACAGA-
GGTGG-3       and 5    -  TATACTCGAGTCACAGAGTGGAATGGTTGTGCTTG-
GCC-3       and then subcloning this fragment into   pUAST-N16   with NheI and 
XhoI.   pUAST-mCD8–Wld 
S     was created by amplifying a 672-bp fragment 
encoding the extracellular and transmembrane domains of mCD8 from 
  pUAST-mCD8–GFP   (  Lee and Luo, 2001  ) and subcloning it into pBluescript-KS 
using BglII and XbaI. The   Wld 
S     open reading frame was then subcloned 
into this plasmid using engineered BglII and XbaI sites to generate   pBlue-
script-KS  –  mCD8–Wld 
S    .   mCD8–Wld 
S     was then subcloned into pUAST 
using BglII and XbaI to generate   pUAST-mCD8–Wld 
S    . 
    pUAST-Nmnat1–myc   was created by amplifying Nmnat1 from the 
pUAST vector (as described for   pUAST-Nmnat1  ) with the primers 5    -GGC-
GAGATCTCAAAACATGGACTCATCCAAGAAGACAGAGGTGG-3     and 
5    -TATTAATCCGCGGCAGAGTGGAATGGTTGTGCTTGG-3     and was 
subsequently cloned into the C-terminal myc pUAST vector with BglII and 
SacII.   pUAST-Nmnat2   was ampliﬁ  ed from mouse cDNA clone BC098007 
(Open Biosystems) using the primers 5    -AATTGATTGCGGCCGCAAAA-
CATGACCGAGACCACAAAGACC-3     and 5    -AATTGTCTAGACTAGCCC-
GAGGCGTTGATGTACAGC-3     and subsequently cloned into pUAST with 
NotI and XbaI.   pUAST-Nmnat2–myc   was ampliﬁ  ed from the same clone as 
Nmnat2 with the primers 5    -AATTGATTGCGGCCGCAAAACATGACC-
GAGACCACAAAGACC-3     and 5    -ATTAATATTAGCGGCCGCGTGCCC-
GAGGCGTTGATGTACAGCTGACTCTTGAG-3     and subsequently cloned 
into C-terminal myc pUAST vector with NotI. 
    pUAST-Nmnat3   was ampliﬁ  ed from mouse cDNA clone BC092086 
(Open Biosystems) using the primers 5    -ACTTATATGCGGCCGCAAAA-
CATGAAGAACCGAATTCCCTGTGGTGC-3     and 5    -AGCAGTCTAGAC-
TAGCCAGTCTTTCCTTTCCC-3     and was subsequently cloned into pUAST 
with NotI and XbaI.   pUAST-Nmnat3–myc   was ampliﬁ   ed from the same 
clone as Nmnat3 using the primers 5    -ACTTATATGCGGCCGCAAAACAT-
GAAGAACCGAATTCCCTGTGGTGC-3     and 5    -TATAATTAGCGGCCGC-
GTGCCAGTCTTTCCTTTCCCTTTCCAGGAACCGTCATTGATG-3     and was 
subsequently cloned into C-terminal myc pUAST vector with NotI. 
    pUAST-NADS   was ampliﬁ  ed from cDNA clone LD11409 (Berkeley 
Drosophila Genome Project) using the primers 5    -GATCGAATTCCAAAA-
CATGGGACGCAAGGTGACCGTAGCGG-3     and 5    -GATCCTCGAGC-
TAGACGGGAATACCGGTGCGA-3     and was subsequently cloned into 
pUAST with EcoRI and XhoI.   pUAST-N16–NADS   was ampliﬁ  ed from the 
same clone as NADS with the primers 5    -GATCGAATTCCAAAACATG-
GAAGAACTGAGCGCGGATGAAATTCGCCGCCGCCGCCTGGCGCG-
CATGGGACGCAAGGTGACCGTAGCGG-3     and 5    -GATCCTCGAGC-
TAGACGGGAATACCGGTGCGA-3     and subsequently cloned into pUAST 
with EcoRI and XhoI. 
  Axon injury protocol 
  Antennal ablations were performed on animals carrying   OR22a-Gal4  , 
  UAS-mCD8–GFP  , and the indicated constructs. 1 wk after eclosion, both 513 IN VIVO FUNCTIONAL DISSECTION OF WLD 
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